As cancer care NMSCO who experience the challenges of providing quality cancer care first-hand, NMSCO members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.
We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!
The 2024 Physician Fee Schedule included 7 new codes specific to care management. This webinar reviews how these differ from the care management codes available from the American Medical Association, common questions, and challenges for implementing these new codes.
Access a PDF of the slides here.The 2024 Physician Fee Schedule includes four new codes specific to Principal Illness Navigation–Peer Support. With these new codes, providers will be able to bill for the services of navigators, social workers, and support personnel. This webinar goes into a deep dive, reviewing components of the new codes, answering common questions, and addressing challenges for providers.
Access a PDF of the slides here.
The American Medical Association (AMA) released a coding update for oncology navigation services in alignment with The Cancer Moonshot program. Featuring discussion on the updates and guidelines from the AMA and review of the components of the AMA’s codes, how these differ from the codes from CMS, and challenges for providers.
Access a PDF of the slides here.
The 2024 Physician Fee Schedule includes seven new codes specific to CHI services, SDOH Risk Assessment, and Principal Illness Navigation–Peer Support. With these new codes, providers can bill for the services of navigators, social workers, and support personnel. This final installment reviews the components of these new codes, common questions, and challenges for providers.
Access a PDF of the slides here.
July 13, 2022
The New Mexico Society of Clinical Oncology (NMSCO) is pleased to announce the passing of HB 129: Pharmacy Benefit Manager Reporting.
We appreciate and thank the oncology community and NMSCO President Barbara McAneny, MD, FACP, FASCO, New Mexico Oncology Hematology Consultants, Ltd., for testifying and supporting this critical piece of legislation.
July 13, 2022
The New Mexico Society of Clinical Oncology (NMSCO) and Association for Clinical Oncology (ASCO) collaborated on a joint support letter for HB 129: Pharmacy Benefit Manager Reporting, which would require pharmacy benefit managers to report aggregate rebate data to the Office of the Superintendent of Insurance and pass the savings they receive from rebates on to the patient. Read support letter.